An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults
Clinical trial NCT03334695 · COMPLETED
Trial details
- NCT number
- NCT03334695
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2018-07-10
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.